Featured Research

from universities, journals, and other organizations

Failure To Take Seizure Drugs Linked To Increased Risk Of Death

Date:
June 18, 2008
Source:
American Academy of Neurology
Summary:
People with epilepsy who fail to take their seizure medication regularly could be as much as three times more likely to die, according to a new study.

People with epilepsy who fail to take their seizure medication regularly could be as much as three times more likely to die, according to a study published in the June 18, 2008, online issue of Neurology.

For the study, researchers looked at insurance records from three U.S. state Medicaid programs over eight and a half years. The study included 33,658 people with epilepsy who filled at least two epilepsy drug prescriptions.

The study found that people who took their epilepsy medication less than 80 percent of the time over the course of three months appeared to be three times more likely to die compared to people who took their medication regularly in a three-month period.

In addition, the study showed that hospital visits went up by 86 percent and emergency room visits increased by 50 percent during the time when people didn't take their medication regularly. There also appeared to be a significantly higher incidence of car accidents and bone breaks. Only head injuries were less common during periods of non-compliance with epilepsy drugs.

"These results are concerning since some studies show about 30 to 50 percent of people with epilepsy do not take their medication regularly," said study author Edward Faught, MD, Director of the University of Alabama Epilepsy Center in Birmingham and Fellow of the American Academy of Neurology.

"There are many reasons epileptic patients fail to take their seizure medications, including cost, side effects and pregnancy. But this study suggests that none of those reasons overshadow the threat of death or other problems related to uncontrolled seizures. Patients need to stay on their medications and physicians need to recognize and treat issues related to people failing to take epilepsy drugs," said Faught.

The study was supported by GlaxoSmithKline.


Story Source:

The above story is based on materials provided by American Academy of Neurology. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Neurology. "Failure To Take Seizure Drugs Linked To Increased Risk Of Death." ScienceDaily. ScienceDaily, 18 June 2008. <www.sciencedaily.com/releases/2008/06/080618161549.htm>.
American Academy of Neurology. (2008, June 18). Failure To Take Seizure Drugs Linked To Increased Risk Of Death. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/06/080618161549.htm
American Academy of Neurology. "Failure To Take Seizure Drugs Linked To Increased Risk Of Death." ScienceDaily. www.sciencedaily.com/releases/2008/06/080618161549.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins